Trials, Tech, and Triumphs of Drug Repurposing is a comprehensive study positioned at the intersection of pharmacology, computational biology and clinical sciences. It explores one of the most promising strategies in modern pharmaceutical research, repurposing existing drugs for new therapeutic applications. The book highlights landmark success stories, including repurposed treatments for cancer, neurodegenerative disorders such as Parkinson's and Alzheimer's disease, and emerging global health challenges like COVID-19, examining how interdisciplinary approaches, including molecular docking, genomic profiling, bioinformatics, phenotypic screening, and artificial intelligence, are transforming the identification of new therapeutic uses for approved drugs. By integrating computational innovation with experimental and clinical insights, this book offers a forward-looking perspective on how drug repurposing can accelerate treatment development, reduce costs, and enable personalised medicine, ultimately reshaping the future of global healthcare.Key Features Provides a comprehensive overview of the history, principles, and evolution of drug repurposingIntegrates computational tools such as molecular docking, bioinformatics, and AI-driven drug discoveryExploration of molecular mechanisms and pathways involved in repurposed drug actionCase studies highlighting applications in cancer, neurodegenerative diseases, and infectious diseasesDiscussions on regulatory, ethical, and clinical considerations in repurposing existing drugsProvides insights into personalised medicine and emerging interdisciplinary research approachesTarget ReadershipResearchers, academics, students, and professionals in pharmacology, biotechnology, bioinformatics, computational biology, and biomedical engineering.

Trials, Tech, and Triumphs of Drug Repurposing is a comprehensive study positioned at the intersection of pharmacology, computational biology and clinical sciences. It explores one of the most promising strategies in modern pharmaceutical research, repurposing existing drugs for new therapeutic applications. The book highlights landmark success stories, including repurposed treatments for cancer, neurodegenerative disorders such as Parkinson's and Alzheimer's disease, and emerging global health challenges like COVID-19, examining how interdisciplinary approaches, including molecular docking, genomic profiling, bioinformatics, phenotypic screening, and artificial intelligence, are transforming the identification of new therapeutic uses for approved drugs. By integrating computational innovation with experimental and clinical insights, this book offers a forward-looking perspective on how drug repurposing can accelerate treatment development, reduce costs, and enable personalised medicine, ultimately reshaping the future of global healthcare.Key Features Provides a comprehensive overview of the history, principles, and evolution of drug repurposingIntegrates computational tools such as molecular docking, bioinformatics, and AI-driven drug discoveryExploration of molecular mechanisms and pathways involved in repurposed drug actionCase studies highlighting applications in cancer, neurodegenerative diseases, and infectious diseasesDiscussions on regulatory, ethical, and clinical considerations in repurposing existing drugsProvides insights into personalised medicine and emerging interdisciplinary research approachesTarget ReadershipResearchers, academics, students, and professionals in pharmacology, biotechnology, bioinformatics, computational biology, and biomedical engineering.

Trials, Tech, and Triumphs of Drug Repurposing is a comprehensive study positioned at the intersection of pharmacology, computational biology and clinical sciences. It explores one of the most promising strategies in modern pharmaceutical research, repurposing existing drugs for new therapeutic applications. The book highlights landmark success stories, including repurposed treatments for cancer, neurodegenerative disorders such as Parkinson's and Alzheimer's disease, and emerging global health challenges like COVID-19, examining how interdisciplinary approaches, including molecular docking, genomic profiling, bioinformatics, phenotypic screening, and artificial intelligence, are transforming the identification of new therapeutic uses for approved drugs. By integrating computational innovation with experimental and clinical insights, this book offers a forward-looking perspective on how drug repurposing can accelerate treatment development, reduce costs, and enable personalised medicine, ultimately reshaping the future of global healthcare.Key Features Provides a comprehensive overview of the history, principles, and evolution of drug repurposingIntegrates computational tools such as molecular docking, bioinformatics, and AI-driven drug discoveryExploration of molecular mechanisms and pathways involved in repurposed drug actionCase studies highlighting applications in cancer, neurodegenerative diseases, and infectious diseasesDiscussions on regulatory, ethical, and clinical considerations in repurposing existing drugsProvides insights into personalised medicine and emerging interdisciplinary research approachesTarget ReadershipResearchers, academics, students, and professionals in pharmacology, biotechnology, bioinformatics, computational biology, and biomedical engineering.